NCT07318805 2026-04-20
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Pfizer
Phase 1 Recruiting
Pfizer
IDEAYA Biosciences
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Seagen Inc.
Pfizer
ImmunityBio, Inc.